Sendi Pedram, Schellenberg Fabian, Ungsedhapand Chaiwat, Kaufmann Gilbert R, Bucher Heiner C, Weber Rainer, Battegay Manuel
Division of Infectious Diseases, Basel University Hospital, Basel, Switzerland.
Clin Ther. 2004 May;26(5):791-800. doi: 10.1016/s0149-2918(04)90080-x.
In HIV-infected patients, reduced ability to work may be an important component of the societal costs of this disease. Few data about productivity costs in HIV-infected patients are available.
The goals of this study were to estimate productivity costs in the HIV-infected population in Switzerland and to identify characteristics that may influence patient productivity.
This cross-sectional study included all patients younger than retirement age (65 years for men and 62 years for women) who were enrolled in the Swiss HIV Cohort Study in 2002. Measures of productivity losses in this population were based on patients' ability to work and the median monthly wage rates adjusted for age, sex, and educational level in Switzerland. Factors associated with ability to work were analyzed in a multivariate ordinary logistic regression (proportional odds) model. As of July 1, 2002, the exchange rate for US dollars to Swiss francs (CHF) was US $1.00 approximately equal to CHF 1.48.
A total of 5319 HIV-infected patients (3665 men [68.9%] and 1655 women [31.1%]; mean [SD] age, 40.6 [8.4] years; range, 17-64 years) were included in the study. The mean annual productivity loss per patient was estimated at CHF 22,910 (95% CI, CHF 22,064-CHF 23, 756). Ability to work was independently associated with the following (P < 0.001 for all): age (10-year increase: odds ratio [OR], 0.60 [95% CI, 0.54-0.62]), sex (female/male: OR, 0.73 [95% CI, 0.63-0.84]), history of IV drug use (OR, 0.22 [95% CI, 0.19-0.26]), time since first positive HIV test (>10 years vs < or = 10 years: OR, 0.66 [95% CI, 0.58-0.76]), CD4 cell count (201-500 vs 0-200 cells/microL: OR, 1.68 [95% CI, 1.38-2.46]; > or =501 vs 0-200 cells/microL: OR, 2.01 [95%, CI, 1.64-2.46]), history of AIDS-indicator disease (OR, 0.47 [95% CI, 0.41-0.55]), stable partnership during the last 6 months (OR, 1.63 [95% CI, 1.43-1.86]), and educational level (higher vs basic: OR, 1.68 [95% CI, 1.45-1.95]).
Productivity losses to society for the HIV-infected population appeared to be substantial in this analysis. Given a patient's clinical health status, a higher education level and a stable partnership were associated with greater ability to work. Socioeconomic characteristics may influence the cost-effectiveness of health care interventions in HIV-infected patients.
在感染HIV的患者中,工作能力下降可能是该疾病社会成本的一个重要组成部分。关于HIV感染患者生产力成本的数据很少。
本研究的目的是估计瑞士HIV感染人群的生产力成本,并确定可能影响患者生产力的特征。
这项横断面研究纳入了2002年参加瑞士HIV队列研究的所有未到退休年龄(男性65岁,女性62岁)的患者。该人群生产力损失的衡量基于患者的工作能力以及根据瑞士年龄、性别和教育水平调整后的月工资中位数。在多变量普通逻辑回归(比例优势)模型中分析与工作能力相关的因素。截至2002年7月1日,美元与瑞士法郎(CHF)的汇率约为1.00美元等于1.48瑞士法郎。
本研究共纳入5319例HIV感染患者(3665例男性[68.9%]和1655例女性[31.1%];平均[标准差]年龄为40.6[8.4]岁;范围为17 - 64岁)。估计每名患者每年的生产力损失为22,910瑞士法郎(95%CI,22,064 - 23,756瑞士法郎)。工作能力与以下因素独立相关(所有P < 0.001):年龄(每增加10岁:优势比[OR],0.60[95%CI,0.54 - 0.62])、性别(女性/男性:OR,0.73[95%CI,0.63 - 0.84])、静脉吸毒史(OR,0.22[95%CI,0.19 - 0.26])、首次HIV检测呈阳性后的时间(>10年与≤10年:OR,0.66[9�%CI,0.58 - 0.76])、CD4细胞计数(201 - 500个细胞/微升与0 - 200个细胞/微升:OR,1.68[95%CI,1.38 - 2.46];≥501个细胞/微升与0 - 200个细胞/微升:OR,2.01[95%CI,1.64 - 2.46])、艾滋病指标疾病史(OR,0.47[95%CI,0.41 - 0.55])、过去6个月内有稳定伴侣关系(OR,1.63[95%CI,1.43 - 1.86])以及教育水平(高等与基础:OR,1.68[95%CI,1.45 - 1.9�])。
在本分析中,HIV感染人群给社会造成的生产力损失似乎很大。考虑到患者的临床健康状况,较高的教育水平和稳定的伴侣关系与更强的工作能力相关。社会经济特征可能会影响针对HIV感染患者的医疗保健干预措施的成本效益。